These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 15349952)

  • 1. Release-modulating factors strongly affecting steroid diffusion from silicone elastomer.
    Nash HA; Robertson DN; Evans SJ
    J Pharm Sci; 2004 Oct; 93(10):2420-30. PubMed ID: 15349952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlling levonorgestrel binding and release in a multi-purpose prevention technology vaginal ring device.
    Murphy DJ; Boyd P; McCoy CF; Kumar S; Holt JD; Blanda W; Brimer AN; Malcolm RK
    J Control Release; 2016 Mar; 226():138-47. PubMed ID: 26878974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards a dapivirine and levonorgestrel multipurpose vaginal ring: Investigations into the reaction between levonorgestrel and addition-cure silicone elastomers.
    Dallal Bashi YH; McCoy CF; Murphy DJ; Boyd P; Spence P; Kleinbeck K; Devlin B; Malcolm RK
    Int J Pharm; 2019 Oct; 569():118574. PubMed ID: 31352053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid state
    McCoy CF; Apperley DC; Variano B; Sussman H; Loeven D; Boyd P; Malcolm RK
    Int J Pharm; 2018 Sep; 548(1):689-697. PubMed ID: 30016672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone.
    Gonzalo IT; Swerdloff RS; Nelson AL; Clevenger B; Garcia R; Berman N; Wang C
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3562-72. PubMed ID: 12161475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental design for optimizing drug release from silicone elastomer matrix and investigation of transdermal drug delivery.
    Snorradóttir BS; Gudnason PI; Thorsteinsson F; Másson M
    Eur J Pharm Sci; 2011 Apr; 42(5):559-67. PubMed ID: 21371556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of anti-inflammatory drugs from a silicone elastomer matrix system.
    Snorradóttir BS; Gudnason PI; Scheving R; Thorsteinsson F; Másson M
    Pharmazie; 2009 Jan; 64(1):19-25. PubMed ID: 19216226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradation and biocompatibility of contraceptive-steroid-loaded poly (DL-lactide-co-glycolide) injectable microspheres: in vitro and in vivo study.
    Dhanaraju MD; Rajkannan R; Selvaraj D; Jayakumar R; Vamsadhara C
    Contraception; 2006 Aug; 74(2):148-56. PubMed ID: 16860053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative levonorgestrel plasma level measurements in patients with regular and prolonged use of the levonorgestrel-releasing intrauterine system.
    Seeber B; Ziehr SC; Gschlieβer A; Moser C; Mattle V; Seger C; Griesmacher A; Concin N; Concin H; Wildt L
    Contraception; 2012 Oct; 86(4):345-9. PubMed ID: 22402256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of an immunoaffinity chromatography column for the selective extraction of trace contraceptive drug levonorgestrel from water samples.
    Qiao Y; Yang H; Wang B; Song J; Deng A
    Talanta; 2009 Nov; 80(1):98-103. PubMed ID: 19782197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled release of levonorgestrel from biodegradable poly(D,L-lactide-co-glycolide) microspheres: in vitro and in vivo studies.
    Wang SH; Zhang LC; Lin F; Sa XY; Zuo JB; Shao QX; Chen GS; Zeng S
    Int J Pharm; 2005 Sep; 301(1-2):217-25. PubMed ID: 16040213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levonorgestrel implants as a contraceptive in captive white-tailed deer.
    White LM; Warren RJ; Fayrer-Hosken RA
    J Wildl Dis; 1994 Apr; 30(2):241-6. PubMed ID: 8028109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of some practical aspects of high temperature liquid chromatography in pharmaceutical applications.
    Berta R; Babják M; Gazdag M
    J Pharm Biomed Anal; 2011 Feb; 54(3):458-62. PubMed ID: 20934825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of long acting subcutaneous levonorgestrel (LNG) gel depot as an effective contraceptive option for cotton-top tamarins (Saguinus oedipus).
    Wheaton CJ; Savage A; Shukla A; Neiffer D; Qu W; Sun Y; Lasley BL
    Zoo Biol; 2011; 30(5):498-522. PubMed ID: 20938969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled release of a model antibacterial drug from a novel self-lubricating silicone biomaterial.
    Malcolm RK; McCullagh SD; Woolfson AD; Gorman SP; Jones DS; Cuddy J
    J Control Release; 2004 Jun; 97(2):313-20. PubMed ID: 15196758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum levels of levonorgestrel during long-term use of Norplant].
    Du M; Shao Q; Zhou X
    Zhonghua Fu Chan Ke Za Zhi; 1999 Jun; 34(6):363-5. PubMed ID: 11360617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of silicone elastomer solubility and diffusivity on the in vitro release of drugs from intravaginal rings.
    Malcolm K; Woolfson D; Russell J; Tallon P; McAuley L; Craig D
    J Control Release; 2003 Jun; 90(2):217-25. PubMed ID: 12810304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contraceptive effects of levonorgestrel in the domestic cat.
    Baldwin CJ; Peter AT; Bosu WT; Dubielzig RR
    Lab Anim Sci; 1994 Jun; 44(3):261-9. PubMed ID: 7933974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of impurities on estradiol crystallization in a sustained-release implant.
    Needham GF; Pfeiffer RR; Engel GL; Rutherford BS; Allen DJ
    J Pharm Sci; 1992 Oct; 81(10):1012-4. PubMed ID: 1432611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A biodegradable levonorgestrel-releasing implant made of PCL/F68 compound as tested in rats and dogs.
    Ma G; Song C; Sun H; Yang J; Leng X
    Contraception; 2006 Aug; 74(2):141-7. PubMed ID: 16860052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.